{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:29:57Z","timestamp":1786667397329,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003202"],"award-info":[{"award-number":["82003202"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX0074"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0074"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX0952"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0952"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neoadjuvant chemotherapy (NAC) is a key component of the standard treatment regimen for patients with advanced esophageal squamous cell carcinoma (ESCC); however, a substantial proportion of patients fail to benefit from NAC because of intrinsic or acquired chemoresistance, leading to disease progression. Aberrant promoter methylation of tumor suppressor genes has been implicated in the diminished chemotherapy response in patients with ESCC. In this study, we show that hypermethylation of the CpG island of the T-box Transcription Factor 1 (TBX1) promoter is frequently associated with nonresponse to NAC in patients with ESCC. Functional experiments indicate that TBX1 suppresses ESCC cell proliferation, induces apoptosis, and increases cisplatin sensitivity. Mechanistically, TBX1 activates the Hippo signaling pathway through two complementary mechanisms: transcriptional upregulation of MST1 and LATS1 and inhibition of F-actin polymerization. Restoration of TBX1 expression enhances chemosensitivity and reduces tumor growth in vivo. Collectively, our findings suggest that TBX1 promoter hypermethylation has the potential to serve as a predictive biomarker of the NAC response in ESCC and define an epigenetic mechanism in which TBX1 silencing contributes to chemoresistance through impairment of Hippo pathway activation. These results suggest that modulating TBX1 expression and Hippo pathway activity represents a potential therapeutic strategy for overcoming chemoresistance in ESCC.<\/jats:p>","DOI":"10.1038\/s41419-026-08934-4","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T13:05:09Z","timestamp":1781010309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epigenetic silencing of TBX1 inactivates the Hippo pathway to potentiate chemoresistance in esophageal squamous cell carcinoma"],"prefix":"10.1038","volume":"17","author":[{"given":"Zhong","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9480-5787","authenticated-orcid":false,"given":"Weiyan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4495-5955","authenticated-orcid":false,"given":"Lin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"8934_CR1","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/S0140-6736(24)02226-8","volume":"404","author":"H Yang","year":"2024","unstructured":"Yang H, Wang F, Hallemeier CL, Lerut T, Fu J. Oesophageal cancer. Lancet. 2024;404:1991\u20132005.","journal-title":"Lancet"},{"key":"8934_CR2","doi-asserted-by":"publisher","first-page":"5062","DOI":"10.1200\/JCO.2009.22.2083","volume":"27","author":"WH Allum","year":"2009","unstructured":"Allum WH, Stenning SP, Bancewicz J, Clark PI, Langley RE. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol. 2009;27:5062\u20137.","journal-title":"J Clin Oncol"},{"key":"8934_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/cac2.12645","volume":"45","author":"W Jiang","year":"2025","unstructured":"Jiang W, Zhang B, Xu J, Xue L, Wang L. Current status and perspectives of esophageal cancer: a comprehensive review. Cancer Commun. 2025;45:281\u2013331.","journal-title":"Cancer Commun"},{"key":"8934_CR4","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"P Van Hagen","year":"2012","unstructured":"Van Hagen P, Hulshof MCCM, Van Lanschot JJB, Steyerberg EW, Henegouwen MIVB, Wijnhoven BPL, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074\u201384.","journal-title":"N Engl J Med"},{"key":"8934_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-022-00873-8","volume":"7","author":"Y Xi","year":"2022","unstructured":"Xi Y, Lin Y, Guo W, Wang X, Zhao H, Miao C, et al. Multi-omic characterization of genome-wide abnormal DNA methylation reveals diagnostic and prognostic markers for esophageal squamous-cell carcinoma. Sig Transduct Target Ther. 2022;7:53.","journal-title":"Sig Transduct Target Ther"},{"key":"8934_CR6","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.cgh.2006.03.007","volume":"4","author":"JP Hamilton","year":"2006","unstructured":"Hamilton JP, Sato F, Greenwald BD, Suntharalingam M, Krasna MJ, Edelman MJ, et al. Promoter methylation and response to chemotherapy and radiation in esophageal cancer. Clin Gastroenterol Hepatol. 2006;4:701\u20138.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8934_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/bs.ctdb.2016.08.006","volume":"122","author":"TK Ghosh","year":"2017","unstructured":"Ghosh TK, Brook JD, Wilsdon A. T-Box genes in human development and disease. Curr Top Dev Biol. 2017;122:383\u2013415.","journal-title":"Curr Top Dev Biol"},{"key":"8934_CR8","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/S0140-6736(03)14632-6","volume":"362","author":"H Yagi","year":"2003","unstructured":"Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, Minoshima S, et al. Role of TBX1 in human del22q11.2 syndrome. Lancet. 2003;362:1366\u201373.","journal-title":"Lancet"},{"key":"8934_CR9","doi-asserted-by":"publisher","DOI":"10.1242\/dev.204524","volume":"152","author":"O Lanzetta","year":"2025","unstructured":"Lanzetta O, Bilio M, Liebig J, Jechow K, Wei Ten F, Ferrentino R, et al. Tbx1 stabilizes differentiation of the cardiopharyngeal mesoderm and drives morphogenesis in the pharyngeal apparatus. Development. 2025;152:dev204524.","journal-title":"Development"},{"key":"8934_CR10","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1089\/thy.2018.0312","volume":"29","author":"N Wang","year":"2019","unstructured":"Wang N, Li Y, Wei J, Pu J, Liu R, Yang Q, et al. TBX1 functions as a tumor suppressor in thyroid cancer through inhibiting the activities of the PI3K\/AKT and MAPK\/ERK pathways. Thyroid. 2019;29:378\u201394.","journal-title":"Thyroid"},{"key":"8934_CR11","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1080\/21655979.2021.1880732","volume":"12","author":"H Liu","year":"2021","unstructured":"Liu H, Song M, Sun X, Zhang X, Miao H, Wang Y. T-box transcription factor TBX1, targeted by microRNA-6727-5p, inhibits cell growth and enhances cisplatin chemosensitivity of cervical cancer cells through AKT and MAPK pathways. Bioengineered. 2021;12:565\u201377.","journal-title":"Bioengineered"},{"key":"8934_CR12","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/mc.20768","volume":"50","author":"CS Trempus","year":"2011","unstructured":"Trempus CS, Wei S, Humble MM, Dang H, Bortner CD, Sifre MI, et al. A novel role for the T-box transcription factor Tbx1 as a negative regulator of tumor cell growth in mice. Mol Carcinogen. 2011;50:981\u201391.","journal-title":"Mol Carcinogen"},{"key":"8934_CR13","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41392-022-01191-9","volume":"7","author":"M Fu","year":"2022","unstructured":"Fu M, Hu Y, Lan T, Guan KL, Luo T, Luo M. The Hippo signalling pathway and its implications in human health and diseases. Sig Transduct Target Ther. 2022;7:376.","journal-title":"Sig Transduct Target Ther"},{"key":"8934_CR14","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1146\/annurev-biochem-013118-111829","volume":"88","author":"S Ma","year":"2019","unstructured":"Ma S, Meng Z, Chen R, Guan KL. The Hippo pathway: biology and pathophysiology. Annu Rev Biochem. 2019;88:577\u2013604.","journal-title":"Annu Rev Biochem"},{"key":"8934_CR15","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2333790","volume":"16","author":"N Wang","year":"2024","unstructured":"Wang N, Zhang L, Leng XX, Xie YL, Kang ZR, Zhao LC, et al. Fusobacterium nucleatum induces chemoresistance in colorectal cancer by inhibiting pyroptosis via the Hippo pathway. Gut Microbes. 2024;16:2333790.","journal-title":"Gut Microbes"},{"key":"8934_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06076-5","volume":"14","author":"T Han","year":"2023","unstructured":"Han T, Chen T, Chen L, Li K, Xiang D, Dou L, et al. HLF promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathway. Cell Death Dis. 2023;14:606.","journal-title":"Cell Death Dis"},{"key":"8934_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.274027.115","volume":"30","author":"Z Meng","year":"2016","unstructured":"Meng Z, Moroishi T, Guan KL. Mechanisms of Hippo pathway regulation. Genes Dev. 2016;30:1\u201317.","journal-title":"Genes Dev"},{"key":"8934_CR18","doi-asserted-by":"publisher","first-page":"42987","DOI":"10.1074\/jbc.M208538200","volume":"277","author":"H Glantschnig","year":"2002","unstructured":"Glantschnig H, Rodan GA, Reszka AA. Mapping of MST1 kinase sites of phosphorylation. J Biol Chem. 2002;277:42987\u201396.","journal-title":"J Biol Chem"},{"key":"8934_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1281-7","volume":"10","author":"H Wu","year":"2019","unstructured":"Wu H, Zhang W, Wu Z, Liu Y, Shi Y, Gong J, et al. miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma. Cell Death Dis. 2019;10:48.","journal-title":"Cell Death Dis"},{"key":"8934_CR20","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.155218","volume":"7","author":"Z Mai","year":"2022","unstructured":"Mai Z, Yuan J, Yang H, Fang S, Xie X, Wang X, et al. Inactivation of Hippo pathway characterizes a poor-prognosis subtype of esophageal cancer. JCI Insight. 2022;7:e155218.","journal-title":"JCI Insight"},{"key":"8934_CR21","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1158\/1078-0432.CCR-14-2191","volume":"21","author":"S Song","year":"2015","unstructured":"Song S, Honjo S, Jin J, Chang SS, Scott AW, Chen Q, et al. The Hippo coactivator YAP1 mediates EGFR overexpression and confers chemoresistance in esophageal cancer. Clin Cancer Res. 2015;21:2580\u201390.","journal-title":"Clin Cancer Res"},{"key":"8934_CR22","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1093\/hmg\/11.18.2091","volume":"11","author":"Q Tao","year":"2002","unstructured":"Tao Q. Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. Hum Mol Genet. 2002;11:2091\u2013102.","journal-title":"Hum Mol Genet"},{"key":"8934_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2217\/epi-2018-0092","volume":"11","author":"L Ye","year":"2019","unstructured":"Ye L, Xiang T, Fan Y, Zhang D, Li L, Zhang C, et al. The 19q13 KRAB Zinc-finger protein ZFP82 suppresses the growth and invasion of esophageal carcinoma cells through inhibiting NF-\u03baB transcription and inducing apoptosis. Epigenomics. 2019;11:65\u201380.","journal-title":"Epigenomics"},{"key":"8934_CR24","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.stem.2024.04.004","volume":"31","author":"JJ Loh","year":"2024","unstructured":"Loh JJ, Ma S. Hallmarks of cancer stemness. Cell Stem Cell. 2024;31:617\u201339.","journal-title":"Cell Stem Cell"},{"key":"8934_CR25","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.7150\/thno.92676","volume":"14","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Chen Y, Guo C, Li P, Cheng Z, Zheng L, et al. Chronic stress dysregulates the Hippo\/YAP\/14-3-3\u03b7 pathway and induces mitochondrial damage in basolateral amygdala in a mouse model of depression. Theranostics. 2024;14:3653\u201373.","journal-title":"Theranostics"},{"key":"8934_CR26","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.cell.2013.07.042","volume":"154","author":"M Aragona","year":"2013","unstructured":"Aragona M, Panciera T, Manfrin A, Giulitti S, Michielin F, Elvassore N, et al. A mechanical checkpoint controls multicellular growth through YAP\/TAZ regulation by actin-processing factors. Cell. 2013;154:1047\u201359.","journal-title":"Cell"},{"key":"8934_CR27","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1038\/emboj.2011.174","volume":"30","author":"HE Richardson","year":"2011","unstructured":"Richardson HE. Actin up for Hippo: actin up for Hippo. EMBO J. 2011;30:2307\u20139.","journal-title":"EMBO J"},{"key":"8934_CR28","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.1038\/s44319-024-00228-0","volume":"25","author":"W Jeong","year":"2024","unstructured":"Jeong W, Kwon H, Park SK, Lee IS, Jho Ehoon. Retinoic acid-induced protein 14 links mechanical forces to Hippo signaling. EMBO Rep. 2024;25:4033\u201361.","journal-title":"EMBO Rep"},{"key":"8934_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ceb.2014.09.003","volume":"31","author":"P Gaspar","year":"2014","unstructured":"Gaspar P, Tapon N. Sensing the local environment: actin architecture and Hippo signalling. Curr Opin Cell Biol. 2014;31:74\u201383.","journal-title":"Curr Opin Cell Biol"},{"key":"8934_CR30","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/s41556-018-0142-z","volume":"20","author":"A Totaro","year":"2018","unstructured":"Totaro A, Panciera T, Piccolo S. YAP\/TAZ upstream signals and downstream responses. Nat Cell Biol. 2018;20:888\u201399.","journal-title":"Nat Cell Biol"},{"key":"8934_CR31","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA A Cancer J Clin"},{"key":"8934_CR32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s00018-022-04131-6","volume":"79","author":"M Lohan-Code\u00e7o","year":"2022","unstructured":"Lohan-Code\u00e7o M, Barambo-Wagner ML, Nasciutti LE, Ribeiro Pinto LF, Meireles Da Costa N, Palumbo A. Molecular mechanisms associated with chemoresistance in esophageal cancer. Cell Mol Life Sci. 2022;79:116.","journal-title":"Cell Mol Life Sci"},{"key":"8934_CR33","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s11912-021-01153-4","volume":"24","author":"JK Waters","year":"2022","unstructured":"Waters JK, Reznik SI. Update on management of squamous cell esophageal cancer. Curr Oncol Rep. 2022;24:375\u201385.","journal-title":"Curr Oncol Rep"},{"key":"8934_CR34","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1053\/j.gastro.2020.09.058","volume":"160","author":"WM Grady","year":"2021","unstructured":"Grady WM, Yu M, Markowitz SD. Epigenetic alterations in the gastrointestinal tract: current and emerging use for biomarkers of cancer. Gastroenterology. 2021;160:690\u2013709.","journal-title":"Gastroenterology"},{"key":"8934_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1543190","volume":"15","author":"J Tang","year":"2025","unstructured":"Tang J, Shi X, Song C, Zhang W, Yan Y, Dai L, et al. DNA methylation in esophageal cancer: technological advances and early detection clinical applications. Front Oncol. 2025;15:1543190.","journal-title":"Front Oncol"},{"key":"8934_CR36","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.7150\/ijms.109161","volume":"22","author":"Z Li","year":"2025","unstructured":"Li Z, Chen X, Li Y, Xu Y, Zhou Y. Aberrant DNA methylation in esophageal squamous cell carcinoma and its clinical implications in systemic chemotherapy. Int J Med Sci. 2025;22:1002\u201314.","journal-title":"Int J Med Sci"},{"key":"8934_CR37","doi-asserted-by":"publisher","first-page":"7396","DOI":"10.1158\/1078-0432.CCR-19-0740","volume":"25","author":"Y Qin","year":"2019","unstructured":"Qin Y, Wu CW, Taylor WR, Sawas T, Burger KN, Mahoney DW, et al. Discovery, validation, and application of novel methylated dna markers for detection of esophageal cancer in plasma. Clin Cancer Res. 2019;25:7396\u2013404.","journal-title":"Clin Cancer Res"},{"key":"8934_CR38","first-page":"3062","volume":"24","author":"R Hu","year":"2020","unstructured":"Hu R, Deng J, Li C, Xu C, Cui ZH, Zhao J. Clinical significance of TBX2 in esophageal squamous cell carcinomas and its role in cell migration and invasion. Eur Rev Med Pharmacol Sci. 2020;24:3062\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"8934_CR39","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2014.10.041","volume":"148","author":"C Palles","year":"2015","unstructured":"Palles C, Chegwidden L, Li X, Findlay JM, Farnham G, Castro Giner F, et al. Polymorphisms near TBX5 and GDF7 are associated with increased risk for barrett\u2019s esophagus. Gastroenterology. 2015;148:367\u201378.","journal-title":"Gastroenterology"},{"key":"8934_CR40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.semcancer.2017.03.010","volume":"44","author":"D Wang","year":"2017","unstructured":"Wang D, Plukker JThM, Coppes RP. Cancer stem cells with increased metastatic potential as a therapeutic target for esophageal cancer. Semin Cancer Biol. 2017;44:60\u20136.","journal-title":"Semin Cancer Biol"},{"key":"8934_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.612451","volume":"9","author":"C Mao","year":"2021","unstructured":"Mao C, Zeng X, Zhang C, Yang Y, Xiao X, Luan S, et al. Mechanisms of pharmaceutical therapy and drug resistance in esophageal cancer. Front Cell Dev Biol. 2021;9:612451.","journal-title":"Front Cell Dev Biol"},{"key":"8934_CR42","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","volume":"740","author":"S Dasari","year":"2014","unstructured":"Dasari S, Bernard Tchounwou P. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 2014;740:364\u201378.","journal-title":"Eur J Pharmacol"},{"key":"8934_CR43","doi-asserted-by":"publisher","first-page":"9443","DOI":"10.7150\/thno.46078","volume":"10","author":"X Zhou","year":"2020","unstructured":"Zhou X, Li Y, Wang W, Wang S, Hou J, Zhang A, et al. Regulation of Hippo\/YAP signaling and esophageal squamous carcinoma progression by an E3 ubiquitin ligase PARK2. Theranostics. 2020;10:9443\u201357.","journal-title":"Theranostics"},{"key":"8934_CR44","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/ng.3076","volume":"46","author":"YB Gao","year":"2014","unstructured":"Gao YB, Chen ZL, Li JG, Hu XD, Shi XJ, Sun ZM, et al. Genetic landscape of esophageal squamous cell carcinoma. Nat Genet. 2014;46:1097\u2013102.","journal-title":"Nat Genet"},{"key":"8934_CR45","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nrc3458","volume":"13","author":"KF Harvey","year":"2013","unstructured":"Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer. 2013;13:246\u201357.","journal-title":"Nat Rev Cancer"},{"key":"8934_CR46","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","volume":"29","author":"F Zanconato","year":"2016","unstructured":"Zanconato F, Cordenonsi M, Piccolo S. YAP\/TAZ at the roots of cancer. Cancer Cell. 2016;29:783\u2013803.","journal-title":"Cancer Cell"},{"key":"8934_CR47","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","volume":"163","author":"FX Yu","year":"2015","unstructured":"Yu FX, Zhao B, Guan KL. Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell. 2015;163:811\u201328.","journal-title":"Cell"},{"key":"8934_CR48","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","volume":"474","author":"S Dupont","year":"2011","unstructured":"Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, et al. Role of YAP\/TAZ in mechanotransduction. Nature. 2011;474:179\u201383.","journal-title":"Nature"},{"key":"8934_CR49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fonc.2018.00055","volume":"8","author":"M Kalli","year":"2018","unstructured":"Kalli M, Stylianopoulos T. Defining the role of solid stress and matrix stiffness in cancer cell proliferation and metastasis. Front Oncol. 2018;8:55.","journal-title":"Front Oncol"},{"key":"8934_CR50","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/ncb2693","volume":"15","author":"C Higashida","year":"2013","unstructured":"Higashida C, Kiuchi T, Akiba Y, Mizuno H, Maruoka M, Narumiya S, et al. F- and G-actin homeostasis regulates mechanosensitive actin nucleation by formins. Nat Cell Biol. 2013;15:395\u2013405.","journal-title":"Nat Cell Biol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08934-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08934-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08934-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:57:54Z","timestamp":1786665474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08934-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8934"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08934-4","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The samples used in this study were from the sample bank of the First Affiliated Hospital of Chongqing Medical University and were strictly approved by the Ethics Review Committee of the First Affiliated Hospital of Chongqing Medical University (Approval No.KX2025-KYC1134-01). All animal experiments were conducted under sterile conditions in pathogen-free facilities designated by Chongqing Medical University. The principles and experimental protocol of the animals used have been approved by the Animal Care and Use Committee of Chongqing Medical University(Approval No.IACUC-CQMU-2024-11017).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"727"}}